Merry Christmas and Happy New Year from Direct Peptides
We’ll be CLOSED on 25th, 26th December, and 1st January. Half-day openings on 27th and 31st December. Back to normal hours on 2nd January. Happy Holidays!

Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
Highest Quality | For Research Use Only

GHRP-6

Buy GHRP-6 Peptide Monaco

GHRP-6, or Growth Hormone Releasing Peptide 6, is a synthetic hexapeptide that acts as a secretagogue to stimulate the pituitary gland’s production and release of human growth hormone (HGH). It functions by binding to the G-protein coupled receptor known as the ghrelin/growth hormone secretagogue receptor (GHSR) located in the anterior pituitary and hypothalamus.

Monaco Research suggests that by stimulating HGH secretion, GHRP-6 can enhance protein synthesis, promote lipolysis, and increase insulin-like growth factor-1 (IGF-1) levels, contributing to improved muscle growth and fat metabolism.

Showing all 10 results

Potential Benefits of GHRP-6 Peptide

  • Prevention of Multiple Organ Failure: GHRP-6 has demonstrated potential in preventing multiple organ failure. Administration of this peptide alone can truncate the effects of organ failure by 50–85%, and additional benefits are seen when GHRP-6 is used in combination with EGF [1].
  • Cardiovascular Benefits: There is evidence to suggest that GHRP-6 may have cardiovascular benefits. Studies have aimed to quantify GHRP-6 in biological matrices to confirm these potential benefits [2].
  • Enhancement of Growth and Immune Responses: GHRP-6 has shown benefits in growth enhancement and immune system stimulation, particularly in aquatic species such as tilapia [3].
  • Improvement of Sleep EEG: There is evidence supporting the impact of GHRP-6 on the nocturnal secretion of GH, ACTH, and cortisol, as well as its influence on the sleep EEG. [4].
  • Muscle Function Benefits: Based on the benefits of GHRP-6 on muscle functions, new medical potentialities are being explored. It has been compared with well-validated cardiovascular drugs like the beta blocker agent metroprolol [5].
  • Increased Feed Intake and Growth Performance: In studies involving gilthead sea bream, feed supplementation with GHRP-6 improved feed intake, growth performance, and aerobic metabolism [6].
  • Potential Treatment for Hypogonadism: GHRP-6 appears to have a potential therapeutic role in ameliorating hypogonadism induced by oxymetholone, an anabolic steroid, in male white rabbits, according to research findings. [7].
  • Therapeutic Candidate for Tissue Damage: There is ongoing research into the pharmacokinetics of GHRP-6, with the peptide being seen as a promising therapeutic candidate for treatment of tissue damage [8].
  • Therapeutic Benefit in Septic Ileus: GHRP-6 has been observed to accelerate gastric emptying more potently than ghrelin in control mice, indicating potential therapeutic benefit in septic ileus [9].

References

[1] https://pubmed.ncbi.nlm.nih.gov/16417467/

[2] https://pubmed.ncbi.nlm.nih.gov/34215058/

[3] https://www.sciencedirect.com/science/ article/abs/pii/S0044848615302428

[4] https://pubmed.ncbi.nlm.nih.gov/10336729/

[5] https://www.sciencedirect.com/science/ article/abs/pii/S0303720714003128

[6] https://www.mdpi.com/2410-3888/7/1/31

[7] https://www.researchgate.net/ publication/365249195

[8] https://pubmed.ncbi.nlm.nih.gov/23099431/

[9] https://pubmed.ncbi.nlm.nih.gov/15305999/

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://monaco.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.